Schering-Plough
This article was originally published in The Tan Sheet
Executive Summary
HealthCare Products division revenues increase 2% to $162 mil. in the third quarter, led by "higher sales" of foot care products, the firm reports Oct. 21. Schering markets the Dr. Scholl line of foot remedies. Nine-month sales jumped 9% to $582 mil. due to increased sales of sun care (Coppertone) and foot care products. A 42% boost in Claritin antihistamine sales helped the firm's net revenues rise 16% to $2 bil. in the quarter; net earnings grew 21% to $432 mil. in the three-month period